These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3976393)

  • 1. Peptides of the otosclerotic perilymph examined by analytical isotachophoresis.
    Sziklai I; Gróf J; Ribári O; Menyhárt J; Piffko P
    Acta Otolaryngol; 1985; 99(1-2):25-34. PubMed ID: 3976393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of peptides derived from otosclerotic bone in the mechanism of sensorineural hearing loss.
    Sziklai I; Gróf J; Ribári O; Menyhárt J
    Acta Otolaryngol; 1985; 100(3-4):253-9. PubMed ID: 4061075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-collagen proteins of stapedial bone matrix in perilymph of otosclerotic patients.
    Gróf J; Sziklai I; Ribári O; Menyhárt J
    Acta Otolaryngol; 1985; 99(5-6):557-63. PubMed ID: 4024905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perilymph oxygenation in sudden and progressive sensorineural hearing loss.
    Nagahara K; Fisch U; Yagi N
    Acta Otolaryngol; 1983; 96(1-2):57-68. PubMed ID: 6412507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin D activity in otosclerotic bone and perilymph.
    Ribári O; Sziklai I
    Acta Otolaryngol; 1988; 105(5-6):549-52. PubMed ID: 3400459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffusion of the drug combination sulfamethoxazole-trimethoprim. Microdetermination in the perilymph, blood and urine of subjects with otosclerosis].
    Jacob M; Causse J; Gaudy D; Duru C; Causse JB; Puech A
    Pharm Acta Helv; 1982; 57(3):93-6. PubMed ID: 6978490
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha 1-antitrypsin activity of perilymph. Occurrence during progression of otospongiosis.
    Chevance LG; Causse JR; Bergès J
    Arch Otolaryngol; 1976 Jun; 102(6):363-4. PubMed ID: 1084149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dependence of perilymph's chemical properties upon electroacoumetry data of tinnitus aurium during otosclerosis].
    Soldatov IB; As'kova LN; Mirkina AIa
    Zh Ushn Nos Gorl Bolezn; 1977; (2):11-5. PubMed ID: 855452
    [No Abstract]   [Full Text] [Related]  

  • 9. Human otosclerotic bone-derived peptide decreases the gain of the electromotility in isolated outer hair cells.
    Sziklai I
    Hear Res; 1996 May; 95(1-2):100-7. PubMed ID: 8793512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Meniere's disease and its subvarieties.
    Kitahara M; Takeda T; Yazawa Y; Matsubara H; Kitano H
    Acta Otolaryngol Suppl; 1984; 406():52-5. PubMed ID: 6332463
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibacterial therapy in surgery of the inner and middle ear. A study of co-trimoxazole penetration into the perilymph (author's transl)].
    Jacob M; Causse J; Gaudy D; Duru C; Causse JB; Puech A
    Nouv Presse Med; 1982 Jun; 11(29):2205-9. PubMed ID: 6981098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potassium and sodium content in the perilymph of patients with otosclerosis].
    Gamov VP; Pal'chun VT
    Vestn Otorinolaringol; 1971; 34(1):8-11. PubMed ID: 5317267
    [No Abstract]   [Full Text] [Related]  

  • 13. [Active otosclerosis of the stapes footplate: histological and clinical aspects of its influence on the perilymph (author's transl)].
    Arnold W; Plester D
    Arch Otorhinolaryngol; 1977 Apr; 215(2):159-78. PubMed ID: 577403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concentration of Na and K ions in the perilymph in otosclerosis].
    Patiakina OK; Samsonov FA; Fedorova VV
    Vestn Otorinolaringol; 1973; 35(2):41-5. PubMed ID: 4705366
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility of Perilymph microRNA Sampling for Identification of Active Gene Expression Pathways in Otosclerosis.
    Wichova H; Shew M; Staecker H
    Otol Neurotol; 2019 Jul; 40(6):710-719. PubMed ID: 31192899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of myosin light-chain kinase activity in the organ of Corti by 0.3-5 kilodalton substances of the otosclerotic perilymph.
    Sziklai I; Kiss JG; Ribári O
    Arch Otorhinolaryngol; 1986; 243(4):229-32. PubMed ID: 3778296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hydrogen ion concentration (pH) of the perilymph in otosclerosis patients].
    Patiakina OK; Samsonov FA
    Zh Ushn Nos Gorl Bolezn; 1976; (5):83-4. PubMed ID: 11619
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of the Ménière attack.
    Dohlman GF
    ORL J Otorhinolaryngol Relat Spec; 1980; 42(1-2):10-9. PubMed ID: 7189270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic acid transport into the cochlear perilymph.
    Rybak LP
    Arch Otorhinolaryngol; 1987; 244(4):204-8. PubMed ID: 3318775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of salicylate in serum and perilymph of the chinchilla.
    Boettcher FA; Bancroft BR; Salvi RJ
    Arch Otolaryngol Head Neck Surg; 1990 Jun; 116(6):681-4. PubMed ID: 2340120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.